研究者

J-GLOBAL ID：201601007900946099 更新日: 2020年06月05日

水野智子

ミズノトモコ | Tomoko Mizuno

所属機関・部署：

研究分野 (1件)：産婦人科学

研究キーワード (2件)：卵巣癌 , 低酸素

MISC (8件)：

Hiroshi Makino, Shin Nishio, Hiroshi Tsubamoto, Muneaki Shimada, Ryutaro Nishikawa, Kentaro Kai, Kimihiko Ito, Tomoko Mizuno, Kimio Ushijima, Ken-ichiro Morishige. Treatment and prognosis of bone metastasis from cervical cancer (KCOG-G1202s). JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH. 2016. 42. 6. 701-706
T. Mizuno, N. Suzuki, H. Makino, T. Furui, E. Morii, H. Aoki, T. Kunisada, M. Yano, S. Kuji, Y. Hirashima, et al. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. GYNECOLOGIC ONCOLOGY. 2015. 137. 2. 299-305
Yasuto Kinose, Kenjiro Sawada, Hiroshi Makino, Tomonori Ogura, Tomoko Mizuno, Noriko Suzuki, Tomoyuki Fujikawa, Eiichi Morii, Koji Nakamura, Ikuko Sawada, et al. IKKβ Regulates VEGF Expression and Is a Potential Therapeutic Target for Ovarian Cancer as an Antiangiogenic Treatment. Molecular cancer therapeutics. 2015. 14. 4. 909-919
Aki Isobe, Kenjiro K Sawada, Yasuto Kinose, Chifumi Ohyagi-Hara, Erika Nakatsuka, Hiroshi Makino, Tomonori Ogura, Tomoko Mizuno, Noriko Suzuki, Eiichi Morii, et al. Interleukin 6 Receptor Is an Independent Prognostic Factor and a Potential Therapeutic Target of Ovarian Cancer. PLOS ONE. 2015. 10. 2
T. Mizuno, H. Takagi, K. Matsunami, A. Imai. Sequential methotrexate treatment with and estrogen and progestin in a retained adhesive placenta. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY. 2010. 37. 4. 331-332

もっと見る

経歴 (1件)：

2013 - 岐阜大学医学部附属病院医員

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM